Drug Profile

Dimethyl sulfoxide - Kyorin Pharmaceutical

Alternative Names: KRP-116D; Zymso

Latest Information Update: 31 Oct 2021

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Kyorin Pharmaceutical
Class Analgesics; Solvents; Sulfoxides
Mechanism of Action Cell membrane permeability enhancers

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

Yes - Interstitial cystitis
New Molecular Entity No

Highest Development Phases

Registered Interstitial cystitis

Most Recent Events

22 Jan 2021 Registered for Interstitial cystitis in Japan (Intravesicular)
18 Dec 2020 Chemical structure information added
22 Oct 2020 Dimethyl sulfoxide is still in Phase-III clinical trials in Interstitial cystitis in Japan (Kyorin Pharmaceutical website, October 2020)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com